Slow And Inconsistent THC Absorption Remains A Key Challenge for Cannabis Manufacturers
Because cannabinoids, like the well-known THC and CBD, are oil-soluble rather than water-soluble, the human body struggles to absorb them efficiently. As a consequence, much of the active ingredient in edible cannabis products is absorbed slowly, intermittently, or hardly at all.
This makes it incredibly difficult for manufacturers to achieve precise dosing and effects in their edibles. It also increases production costs since they often need to include more than the minimum effective dose to compensate for the fact that most of the active ingredients won’t be absorbed.
While smoking or vaping comes with a higher bioavailability of around 30% and a faster response time of seconds or minutes, the respiratory health consequences make it a less-than-ideal option, especially for regular use.
PBI’s UltraShear Nanoemulsion Technology Could Be A Breakthrough In Achieving Precision Dosing for THC, CBD, and Other Products
“This testing has provided dramatic consumer-level validation in the cannabis market for our UltraShear nanoemulsion capabilities and for its expected market-changing impact,” said Mr. Hollister.
For consumers, that means more immediate and consistent effects every time they use an UltraShear processed oral spray or other mechanisms for ingestion. For manufacturers, that improved bioavailability means smaller amounts of THC or CBD are required to achieve an effective dose since the less active ingredient is getting wasted - thus saving the manufacturer money.
“It provides an easy-to-use, reliable, and healthy alternative dosing format, with nearly immediate onset and a consistent experience associated with inhaling, but without the respiratory health risks associated with smoking and vaping. It also eliminates the frustrating delayed effects, imprecision, and frequent overdosing associated with edibles,” said Crème De Canna President, Jonathan Kolodinski.
Featured photo by Gustavo Fring on Pexels
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
